Tech Company Financing Transactions
Matter Neuroscience Funding Round
Arch Venture Partners, Collaborative Fund and EXOR participated in a $26 million funding round for Matter Neuroscience. The round was announced on 2/26/2024.
Transaction Overview
Company Name
Announced On
2/26/2024
Transaction Type
Venture Equity
Amount
$26,000,000
Round
Undisclosed
Proceeds Purpose
Most of Matter's $26 million cash infusion will go toward its continued research. The startup aims to begin three new clinical studies this year.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
3200 Carbon Place 101
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Undisclosed
Website
Email Address
Overview
Matter was founded by neuroscientist Axel Bouchon, who previously led the venture arms for Moderna and Bayer; Ben Goldhirsh of GOOD Worldwide and the Goldhirsh Foundation; and Chris Shiflett of Faculty and Brooklyn Beta. Our first product is an iOS app designed to help you capture the best moments in your life, collect and reflect on your memories of good experiences, understand how those experiences affect you on a molecular level, and use your best memories to shape the life you want.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Founder
Axel Bouchon
Browse more venture capital transactions:
Prev: 2/26/2024: Ad-Shield venture capital transaction
Next: 2/26/2024: Talus Network venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs